Table 1.
Overview of aberrant expression of TRIP13 in human primary tumors and cancer cell lines investigated.
| Tumor type | TRIP13 expression level | Detection method | Reference number |
|---|---|---|---|
| Wilms tumor | Downregulation | RT-PCR, Western blot | [19] |
| Primary cutaneous T-cell lymphoma | Overexpression | RT-PCR | [100] |
| Non-small cell lung cancer | overexpression | Microarray | [104] |
| Lung adenocarcinoma | Overexpression | Q-PCR, Western blot | [87] |
| Breast cancer | Overexpression | Microarray | [[97], [98], [99]] |
| Prostate cancer | Overexpression | Microarray, Q-PCR, Western blot | [88,101] |
| Colorectal cancer | Overexpression | RT-PCR, Microarray, Western blot | [89,102] |
| Squamous cell carcinoma of the head and neck | Overexpression | RT-PCR, Western blot | [66] |
| Chronic lymphocytic leukemia | Overexpression | Q-PCR | [86] |
| Multiple myeloma | Overexpression | Q-PCR | [6,103] |